United Therapeutic (UTHR) Stock Price, Quote & News

Company Profile

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) to d...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 301 608 9292

Website: www.unither.com

Address:

1000 Spring Street, Silver Spring, United States

clan Jun. 16 at 2:43 PM

$MNKD $SNY $UTHR E-Z money↗️ Buy for profits. Hold for riches.

0 · Reply

BNBComedian Jun. 16 at 1:13 PM

$UTHR offcially 12MTH negative return. No dividend. No future. No dickandballs.Clock me out Bina 2000, time to go!

1 · Reply

high_tech_texan Jun. 14 at 3:04 PM

$UTHR Just two shares dropped this to 275 after hours.

1 · Reply

grampslol Jun. 13 at 3:42 PM

$MNKD $UTHR weekly Tyfizzle dpi script numbers used to get posted. Remember, both Tyfizzle dpi and nebulizer tyvaso were given. The actual weekly script count must really stink bigly like afizzle so they keep the actual #'s secret. No transparency..smh...

1 · Reply

firefox2778 Jun. 13 at 3:01 PM

$MNKD $UTHR probably Martine knows what is doing. Competition? Yes sure, but, do you trust her??? That's the real question. I don't think she is selling smog like MC and others on this board. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://ir.unither.com/~/media/Files/U/United-Therapeutics-IR/documents/events-and-presentations/2025-04-30-1q-eps-presentation.pdf

0 · Reply

Omegacy2 Jun. 12 at 5:19 PM

$UTHR 184.5s as i pt 180-182+. i take more off from back in 178 after scalp +8.

0 · Reply

HawkRoseCapital Jun. 12 at 3:41 PM

$MEHCQ $UTHR 🚀 $GEAT is going parabolic - now at $0.0699 (+74.7%) Blink and you’ll miss it👀

0 · Reply

Omegacy2 Jun. 12 at 3:20 PM

$UTHR 182.s as i pt 180-182+ i take some off as high as i can from back in 178. after scalps +8.

0 · Reply

HawkRoseCapital Jun. 12 at 2:39 PM

$MEHCQ $UTHR 🚨 Modern work = skipped lunches, Zoom overruns, late food orders. Still manual in the AI era? Seriously? GEAT fixes this: - Smart meal vouchers - Auto delivery synced to meetings - No clicks. No apps. No delays. It’s not just food. It’s: ✅ Productivity ✅ Morale ✅ Leadership GreetEat Corporation (OTC: GEAT) is the next big disruptor. 🚀

0 · Reply

Bazzzigar Jun. 12 at 2:21 PM

$UTHR $300+

0 · Reply

United Therapeutics: Tanking On Rival's PAH Data - I'd Consider Buying Stock

Apr 30, 2025, 1:09 PM EDT - 6 weeks ago

United Therapeutics Corporation (UTHR) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 6:30 AM EDT - 6 weeks ago

United Therapeutics Corporation Reports First Quarter 2025 Financial Results

Apr 21, 2025, 7:00 AM EDT - 2 months ago

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference

Apr 4, 2025, 7:00 AM EDT - 2 months ago

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the International Society for Heart and Lung Transplantation 45th Annual Meeting and Scientific Sessions

Mar 29, 2025, 8:17 AM EDT - 2 months ago

United Therapeutics: Don't Fear The Patent Expiration Too Much

Mar 4, 2025, 7:00 AM EST - 3 months ago

United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025

Feb 26, 2025, 2:14 PM EST - 3 months ago

United Therapeutics Corporation (UTHR) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 6:30 AM EST - 3 months ago

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 25, 2025, 1:06 AM EST - 4 months ago

United Therapeutics: A Unique Business With High Margins And Expansion Potential

Feb 24, 2025, 7:00 AM EST - 4 months ago

United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference

Feb 19, 2025, 7:00 AM EST - 4 months ago

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025

Feb 4, 2025, 7:00 AM EST - 4 months ago

United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

Feb 3, 2025, 7:00 AM EST - 4 months ago

United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial

Jan 21, 2025, 7:00 AM EST - 5 months ago

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress

Jan 6, 2025, 7:00 AM EST - 5 months ago

United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 29, 2024, 4:25 PM EST - 6 months ago

The Zen Ten - My Top Picks For 2025

AAPL BBW IBKR INTU META NVDA TSM

Dec 17, 2024, 7:00 AM EST - 6 months ago

United Therapeutics Announces Successful World's First UKidney Transplant

Nov 15, 2024, 6:27 PM EST - 7 months ago

United Therapeutics: Competitive Advantages At Such Cheap Multiples Scream Buy

Nov 15, 2024, 7:00 AM EST - 7 months ago

United Therapeutics Expands Into Organ Transplants, But Tyvaso's Legal Battles Loom

Nov 14, 2024, 5:16 PM EST - 7 months ago

United Therapeutics: One To Believe In Despite Competitive Threats

Nov 5, 2024, 4:30 PM EST - 8 months ago

United Therapeutics Corporation to Present at the UBS Global Healthcare Conference

Oct 30, 2024, 3:09 PM EDT - 8 months ago

United Therapeutics Corporation (UTHR) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 6:30 AM EDT - 8 months ago

United Therapeutics Corporation Reports Third Quarter 2024 Financial Results

Oct 23, 2024, 7:00 AM EDT - 8 months ago

United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service

Oct 23, 2024, 6:30 AM EDT - 8 months ago

United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024

Sep 24, 2024, 7:00 AM EDT - 9 months ago

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual Meeting

Sep 10, 2024, 7:00 AM EDT - 10 months ago

United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—Ever

Aug 30, 2024, 12:02 PM EDT - 10 months ago

United Therapeutics Shares Thrive

Aug 28, 2024, 7:00 AM EDT - 10 months ago

United Therapeutics Corporation to Present at Upcoming Investor Conferences

Aug 19, 2024, 10:00 PM EDT - 10 months ago

United Therapeutics: Economics Support Compounding Ability

Jul 31, 2024, 11:28 AM EDT - 11 months ago

United Therapeutics Corporation (UTHR) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 6:30 AM EDT - 11 months ago

United Therapeutics Corporation Reports Second Quarter 2024 Financial Results

Jul 24, 2024, 7:00 AM EDT - 11 months ago

United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024

Jul 10, 2024, 7:00 AM EDT - 1 year ago

United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

Jun 28, 2024, 10:36 AM EDT - 1 year ago

Big Money Elevating United Therapeutics

Jun 27, 2024, 7:00 AM EDT - 1 year ago

United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors

Jun 5, 2024, 7:00 AM EDT - 1 year ago

United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

May 1, 2024, 2:46 PM EDT - 1 year ago

United Therapeutics Corporation (UTHR) Q1 2024 Earnings Call Transcript

May 1, 2024, 6:30 AM EDT - 1 year ago

United Therapeutics Corporation Reports First Quarter 2024 Financial Results

Apr 26, 2024, 2:02 PM EDT - 1 year ago

CORRECTING and REPLACING PHOTO United Therapeutics Announces World's First Successful Xenothymokidney Transplant

Apr 24, 2024, 9:00 AM EDT - 1 year ago

United Therapeutics Announces World's First Successful Xenothymokidney Transplant

Apr 24, 2024, 7:00 AM EDT - 1 year ago

United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024

Apr 16, 2024, 7:00 AM EDT - 1 year ago

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference

Mar 26, 2024, 7:00 AM EDT - 1 year ago

United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation

Mar 25, 2024, 7:00 AM EDT - 1 year ago

United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program

Mar 5, 2024, 6:00 AM EST - 1 year ago

United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024

Feb 27, 2024, 6:00 AM EST - 1 year ago

United Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care Conference

Feb 21, 2024, 2:56 PM EST - 1 year ago

United Therapeutics Corporation (UTHR) Q4 2023 Earnings Call Transcript

Feb 21, 2024, 6:08 AM EST - 1 year ago

United Therapeutics starts litigation with FDA for allowing Liquidia's drug application

LQDA

clan Jun. 16 at 2:43 PM

$MNKD $SNY $UTHR E-Z money↗️ Buy for profits. Hold for riches.

0 · Reply

BNBComedian Jun. 16 at 1:13 PM

$UTHR offcially 12MTH negative return. No dividend. No future. No dickandballs.Clock me out Bina 2000, time to go!

1 · Reply

high_tech_texan Jun. 14 at 3:04 PM

$UTHR Just two shares dropped this to 275 after hours.

1 · Reply

grampslol Jun. 13 at 3:42 PM

1 · Reply

firefox2778 Jun. 13 at 3:01 PM

0 · Reply

Omegacy2 Jun. 12 at 5:19 PM

$UTHR 184.5s as i pt 180-182+. i take more off from back in 178 after scalp +8.

0 · Reply

HawkRoseCapital Jun. 12 at 3:41 PM

$MEHCQ $UTHR 🚀 $GEAT is going parabolic - now at $0.0699 (+74.7%) Blink and you’ll miss it👀

0 · Reply

Omegacy2 Jun. 12 at 3:20 PM

$UTHR 182.s as i pt 180-182+ i take some off as high as i can from back in 178. after scalps +8.

0 · Reply

HawkRoseCapital Jun. 12 at 2:39 PM

0 · Reply

Bazzzigar Jun. 12 at 2:21 PM

$UTHR $300+

0 · Reply

wahoowa96 Jun. 12 at 3:39 AM

$UTHR Buy out ARCT to headstart LP(a) one time gene editing. https://arcturusrx.com/publications-rna-medicines/platform/#:~:text=Lipoprotein(a)%2C%20or%20Lp,deletions%20at%20LPA%20transgene%20loci.

0 · Reply

Omegacy2 Jun. 12 at 1:15 AM

$UTHR 176.4s. tomorrow is 3rd day rules. it should bounce 180-182+ i was in 177 and out 185 7 1st day. today hod 188.s. and i am back in 178 avg. @paladin12

0 · Reply

votetrump24 Jun. 11 at 11:41 PM

$UTHR What’s the news here?

0 · Reply

clan Jun. 11 at 9:47 PM

$MNKD $UTHR Jeff Foxworthy's, "You Might Be A Retard If...." ... you call shares granted execs as part of their Compensation Plan are "free", then .... you are definitely a retard. And you're a retard if you agree/like that "free" comment. #CreeptinProvesRetardationIsIncurable #CreeptinFailedBusiness101 #CommunitySchoolDropout #ProBoardsDEIHire

0 · Reply

Omegacy2 Jun. 11 at 6:13 PM

$UTHR 178.s i add more i got some 183 after scalp in 177 and out 185 yesterday. msgs posted.

1 · Reply

JarvisFlow Jun. 11 at 6:11 PM

B of A Securities has adjusted their stance on United Therapeutics ( $UTHR ), setting the rating to Neutral with a target price of 321 → 315.

0 · Reply

Bazzzigar Jun. 11 at 5:52 PM

$UTHR

0 · Reply

ZacksResearch Jun. 11 at 5:20 PM

$INSM skyrocketed 29% after positive phase IIb data! 🚀 🌟 TPIP led to a placebo-adjusted 35% reduction in pulmonary vascular resistance for PAH patients. 📈 Year to date, INSM shares are up 32%, beating the industry’s 1% decline. See why this breakthrough matters for $UTHR and $LQDA here 👉 https://www.zacks.com/commentary/2494541/insmed-stock-jumps-29-on-encouraging-pah-study-results?cid=sm-stocktwits-2-2494541-body&ADID=SYND_STOCKTWITS_TWEET_2_2494541_BODY

1 · Reply

Omegacy2 Jun. 11 at 4:15 PM

$UTHR i am back in 183.0s after scalp in 177 and out 185.

0 · Reply

PencilNeckGeek Jun. 11 at 2:55 PM

$UTHR bought dip yesterday. Should be back to $300+ shortly

1 · Reply

btrbio Jun. 11 at 2:51 PM

$UTHR Is a solid company with fundamentals to match. I bought more on the dip.

0 · Reply

TheDayTradingAcademy Jun. 11 at 11:26 AM

Shares of U.S based $INSM surged +28.65% on Tuesday at $90.93, after the global biopharmaceutical company announced positive results from a Phase 2b study of treprostinil palmitil inhalation powder, a once-daily treatment for pulmonary arterial hypertension. U.S. based $UTHR fell in turn, dropping -14.32% at $281.36. Insmed stock is up +38.59% in the past month, +31.71% in 2205 & +47.49% y/y, with a market cap of $16.56B. United Therapeutics shares are down -6.11% in the past month, -20.26% in 2025 & -0.18% y/y, with a market cap of $12.69B.

0 · Reply

Market Cap	13.02B
Revenue (ttm)	2.88B
Net Income (ttm)	1.20B
EPS (ttm)	N/A
PE Ratio	11.31
Forward PE	10.42
Profit Margin	41.53%
Debt to Equity Ratio	0.03

Volume	563,600
Avg Vol	555,188
Day's Range	N/A - N/A
Shares Out	45.11M
Stochastic %K	23%
Beta	0.57
Analysts	Strong Sell
Price Target	$389.33